← Back to Search

Aim 2 (survey, training, communication intervention, and environmental scan) for Human Papillomavirus (PROMOTE Trial)

N/A
Waitlist Available
Led By Parth Shah
Research Sponsored by Fred Hutchinson Cancer Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 months after consent
Awards & highlights

PROMOTE Trial Summary

This trialtests a communication strategy to increase HPV vaccination rates in community pharmacies for adolescents. It focuses on awareness of pharmacy services and better engagement of pharmacy staff.

Eligible Conditions
  • Human Papillomavirus (HPV)

PROMOTE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 months after consent
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 months after consent for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of providing HPV vaccination to children and of the proposed communication strategy to support HPV vaccination
Adoption of HPV vaccination
Adoption of other adolescent vaccines
+7 more

PROMOTE Trial Design

2Treatment groups
Experimental Treatment
Group I: Aim I (interview)Experimental Treatment1 Intervention
Participants participate in a semi-structured interview in-person or via phone over 90 minutes about barriers/facilitators of HPV vaccination in pharmacies.
Group II: Aim 2 (survey, training, communication intervention, and environmental scan)Experimental Treatment4 Interventions
Participants provide feedback on survey questions via cognitive testing. Pharmacy staff complete an online survey over 10-15 minutes to assess the acceptability, appropriateness, and feasibility of providing HPV vaccination to children aged 9-17 in their pharmacies. Pharmacy staff then attend two, 60- minute vaccine communication training sessions, consisting of identifying vaccine-eligible children and recommending HPV and other vaccines. Pharmacy staff employ the new communication strategy in their pharmacy up to 6 months, and then complete an online survey over 10-15 minutes. Pharmacies of which the pharmacy staff participants work undergo an environmental scan to characterize the pharmacy's environment, vaccination workflow, and team dynamics.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Healthcare Activity
2021
N/A
~50

Find a Location

Who is running the clinical trial?

Fred Hutchinson Cancer Research CenterLead Sponsor
443 Previous Clinical Trials
148,204 Total Patients Enrolled
Fred Hutchinson Cancer CenterLead Sponsor
556 Previous Clinical Trials
1,343,227 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,112 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is enrollment being sought for this clinical experiment?

"Yes, the information posted on clinicaltrials.gov affirms that this medical trial is actively seeking enrolment. This research was first published on February 1st 2021 and has had updates as recenty as November 29th 2022. 55 patients are being sought at a single site of recruitment."

Answered by AI

Are there current opportunities to participate in this trial?

"Affirmative, this clinical trial is on the hunt for participants. Its initial posting date was February 1st 2021 and it has recently been updated as of November 29th 2022."

Answered by AI
~10 spots leftby Apr 2025